Jade Biosciences (JBIO) has announced the pricing of a public offering of 10M shares of its common stock, priced at $15.00 per share, expected to raise gross proceeds of $150M from this offering. The ...
) has been revised to $28.82 / share. This is an increase of 10.24% from the prior estimate of $26.14 dated March 25, 2026. The price target is an average of many targets provided by analysts. The ...
UBS analyst Michael Yee initiates coverage on Jade Biosciences (NASDAQ:JBIO) with a Buy rating and announces Price Target of $45. Wedbush analyst Laura Chico maintains Jade Biosciences (NASDAQ:JBIO) ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results